Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVATAR: Rosuvastatin for Preventing Myocardial Damage in ACS
NCT01245803Phase 4Unknown
- Sponsor
- Beijing An Zhen Hospital
- Start
- Apr 2010
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in acute coronary syndrome (ACS), sponsored by Beijing An Zhen Hospital. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01245803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245803.